← Back to Clinical Trials
Recruiting NCT06752096

NCT06752096 Robot-Assisted Neurovascular Intervention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06752096
Status Recruiting
Phase
Sponsor Navigantis Inc.
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2024-12-27
Primary Completion 2026-12-01

Trial Parameters

Condition Stroke
Sponsor Navigantis Inc.
Study Type INTERVENTIONAL
Phase N/A
Enrollment 10
Sex ALL
Min Age 18 Years
Max Age 80 Years
Start Date 2024-12-27
Completion 2026-12-01
Interventions
cerebral angiography, arterial embolization, thrombectomyCerebral angiogram using robotic deviceMeningioma embolization using robotic device.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Patients scheduled for neurovascular interventions may be eligible to have their procedure done robotically.

Eligibility Criteria

Inclusion Criteria: Patients scheduled for neurovascular interventions, such as diagnostic cerebral angiography for cerebrovascular diseases, arterial embolization for meningioma treatment, and thrombectomy for thrombotic arterial occlusion-induced cerebral ischemia, are selected according to the same criteria as standard cerebral angiography and interventional procedures. Exclusion Criteria: Exclusion Criteria 1 (General): 1. Patients who have undergone surgery within 4 weeks prior to study participation or have not fully recovered from surgery. 2. Patients who are pregnant or breastfeeding. 3. Patients with existing or anticipated vasospasm, bleeding, or severe atheromatous disease. 4. Patients allergic to contrast agents used in angiography. 5. Patients with renal failure. 6. Patients with a history of cardiac events, such as myocardial infarction or superior vena cava (SVC) syndrome, within 3 months prior to study participation, or with existing heart disease. 7. Patients unable to

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology